Related Experiment Video
Updated: Aug 18, 2026

09:41
Performing and Processing FNA of Anterior Fat Pad for Amyloid
Published on: October 30, 2010
[Is early diagnosis of amyloidosis AL possible? Consideration on a representative case]
Recenti Progressi in Medicina
|April 1, 1996
Abstract:
A male patient, 53 year-old, affected by with amyloidosis AL (AAL) with MGUS IgG lambda shows the renal function and the spiro-index yet normal. There is a cardiomyopathy by amyloidosis, but the kinaemia is yet normal. We think to treat the patient with high dose therapy and PBSCs. The appearance of a heart failure and an asystole after the anaesthesia of marrow-harvest precludes this treatment: once more the diagnosis of amyloidosis AL was late. Is the early diagnosis of AAL possible?
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

